Introduction
Nonketotic hyperglycinemia (NKH) is an autosomal recessive disorder of glycine (Gly) metabolism caused by deficient activity of the glycine cleavage system (GCS) (E.C. 2.1.1.10). Although GCS encompasses 4 different proteins, P-protein (a pyridoxal phosphate-containing protein), T-protein (tetrahydrofolate-requiring amino methyltransferase), L-protein (lipoamide dehydrogenase) and H-protein (lipoic acid containing protein) (Kikuchi et al., 2008) , NKH is usually associated to the deficiency of P-protein and, to a less frequently, of T-protein (Hamosh and Johnston, 2001) . NKH is biochemically characterized by the accumulation of Gly in cerebral spinal fluid (CSF), blood and urine of affected patients, with a significantly characteristic elevation of the CSF/plasma Gly ratio (normal < 0.04). A ratio > 0.08 is usually considered diagnostic of classical NKH and should be followed by the analysis of GCS activity in liver tissue. The overall NKH prevalence is estimated in 1:60,000 newborns (Applegarth et al., 2000) , although higher frequencies were reported in northern Finland, British Columbia and in small Arab villages in Israel (von Wendt et al., 1980; Boneh et al., 2005) . Clinically, most patients have the classical form which appears in the neonatal period with lethargy, coma, seizures and apnea, as well as congenital brain malformations such as agenesis or hypoplasia of the corpus callosum, and the combination of a retrocerebellar cyst with hydrocephalus (Dobyns, 1989; Van Hove et al., 2000) . Patients with late-onset variant forms exhibit a variable degree of mental retardation and seizures (Hamosh and Johnston, 2001; Steiner et al., 1996) . Furthermore, a few patients have been described with the features of neonatal NKH, but the biochemical and clinical symptoms disappeared in infancy. The outcome of these patients has been variable (Aliefendioglu et al., 2003) and the etiology of this form is still unknown at present (Van Hove et al., 2005) . Early treatment consisting of sodium benzoate and dextromethorphan administration improves the neurological Glycine tissue concentrations are increased particularly in nonketotic and ketotic hyperglycinemia, inherited metabolic disorders characterized by severe neurologic damage and brain abnormalities. The present work investigated the in vitro effects of glycine on important parameters of energy metabolism in the brain of young rats. The parameters analyzed were CO 2 generated from glucose, acetate and citrate and the activities of the respiratory chain complexes I-IV, of the citric acid cycle enzymes citrate synthase, aconitase, isocitrate dehydrogenase, a-ketoglutarate dehydrogenase, succinate dehydrogense, fumarase and malate dehydrogenase, of creatine kinase and Na + ,K + -ATPase. Our results show that glycine significantly reduced CO 2 production from acetate, but not from glucose and citrate, reflecting an impairment of the citric acid cycle function. We also observed that the activity of the mitochondrial enzyme citrate synthase was markedly inhibited by glycine, whereas the other activities of the citric acid cycle were not altered. Furthermore, the activity of the respiratory chain was reduced at complexes I-III, II-III and II, as well as of the mitochondrial isoform of creatine kinase and Na + ,K + -ATPase. The data indicate that glycine severely impairs brain bioenergetics at the level of energy formation, transfer and utilization. Considering the importance of energy metabolism for brain development and functioning, it is presumed that glycine-induced impairment of brain energy homeostasis may be involved at least in part in the neurological damage found in patients affected by disorders in which brain glycine concentrations are increased.
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sequelae of these patients, but are usually not very successful (Korman et al., 2006) . Although the pathogenesis of the brain lesions found in NKH is still unknown, it is well recognized that situations with catabolic stress lead to increase of blood Gly tissue concentrations and worsening of patients' symptomatology and that oral Gly load causes electro-encephalographic changes (Frazier et al., 1978) . In addition, it has been reported a correlation between the increase of CSF/plasma Gly ratio and the severity of the disease (Hamosh and Johnston, 2001) . Taken together these observations, it is conceivable that high Gly concentrations are toxic to the brain and are possibly involved in the pathophysiology of brain damage in NKH patients. On the other hand, it is well documented that Gly stimulates NMDA receptors located in the hippocampus, cerebral cortex, olfactory bulb, and cerebellum leading to excitotoxicity (Patel et al., 1990; McNamara and Dingledine, 1990; Hara et al., 1993; Kure et al., 1997; Kono et al., 2007; Katsuki et al., 2007) . In contrast, Gly also acts as an inhibitory neurotransmitter in the brain stem, which can explain apnea, hiccups and hypotonia. However, the underlying mechanisms of brain damage in this disorder are far from being understood. It should be also stressed that increased tissue amounts of Gly are also characteristic of methylmalonic acidemia and propionic acidemia, two inherited metabolic disorders with severe neurological dysfunction and brain cortical atrophy.
Recently, it was demonstrated that Gly induces oxidative stress in cerebral cortex of young rats in vitro, eliciting lipid and protein oxidative damage and reducing the antioxidant defenses (Leipnitz et al., 2008) . However, to our knowledge the effect of Gly on brain energy metabolism remains to be elucidated. Therefore, in the present work we investigated the in vitro influence of Gly on important parameters of cellular energy metabolism, namely CO 2 production from [U- 
Animals
Thirty-day-old Wistar rats weighting 80-100 g obtained from the Central Animal House of the Department of Biochemistry, ICBS, UFRGS, were used in the assays. The animals had free access to water and to a standard commercial chow and were maintained on a 12:12 h light/dark cycle in an air-conditioned constant temperature (22 AE 1 8C) colony room. The ''Principles of Laboratory Animal Care'' (NIH publication no. 80-23, revised 1996) were followed in all experiments and the experimental protocol was approved by the Ethics Committee for Animal Research of the Federal University of Rio Grande do Sul, Porto Alegre, Brazil. All efforts were made to minimize the number of animals used and their suffering.
Cerebral preparations
The animals were sacrificed by decapitation, the brain was rapidly removed and the cerebral cortex was isolated. For CO 2 production, the cerebral cortex was homogenized (1:10, w/v) in Krebs-Ringer bicarbonate buffer, pH 7.4 (KH 2 PO 4 0.016%, NaCl 0.69%, KCl 0.035%, MgSO 4 0.29%, CaCl 2 0.037% and NaHCO 3 5.46%). For the determination of the activities of the respiratory chain complexes I-III, II, II-III and IV, cerebral cortex was homogenized (1:20, w/v) in SETH buffer, pH 7.4 (250 mM sucrose, 2.0 mM EDTA, 10 mM Trizma base and 50 IU mL À1 heparin). The homogenates were centrifuged at 800 Â g for 10 min and the supernatants were kept at À70 8C until being used for enzyme activity determination. For the determination of the activities of citric acid cycle enzymes, mitochondrial enriched fractions from whole brain were prepared according to Rosenthal et al. (1987) , with slight modifications. For total creatine kinase activity determination, the cerebral cortex was homogenized (1:10, w/v) in isosmotic saline solution. For the preparation of mitochondrial and cytosolic fractions, the homogenates were centrifuged at 800 Â g for 10 min at 4 8C and the pellet discarded (Ramirez and Jimenez, 2000) . The supernatant was then centrifuged at 27,000 Â g for 30 min at 4 8C in a Sorval DC-2B centrifuge. The pellet containing the mitochondria was washed three times with saline solution and used as the mitochondrial fraction for the mitochondrial creatine kinase (mCK) enzymatic assay. The supernatants were further centrifuged at 125,000 Â g for 60 min at 4 8C in an OTD-65B Sorval centrifuge, the microsomal pellet discarded, and the cytosol (supernatant) was used for the determination of cytosolic creatine kinase activity. The period between tissue preparation and measurement of the various parameters was always less than 5 days, except for mitochondrial and cytosolic creatine kinase (cCK), citric acid cycle enzymatic and CO 2 production assays, which were performed in the same day of the preparations. The biochemical parameters were determined in the presence of various concentrations of Gly (0.1, 0.5, 1.0 and 5.0 mM), whereas control groups did not contain the amino acid in the incubation medium. Gly was dissolved on the day of the experiments in the buffer used for each technique with pH adjusted to 7.4. We always carried out parallel experiments with blanks (controls) in the presence or absence of Gly and also with or without brain preparations in the reaction medium in order to detect any interference (artifacts) of this amino acid on the techniques utilized to measure the various biochemical parameters. The effects of alanine on some biochemical parameters were also tested.
Preparation of synaptic plasma membrane from rat whole brain
Tissue was homogenized in 10 volumes of 0.32 mM sucrose solution containing 5.0 mM HEPES and 1.0 mM EDTA. Membranes were prepared afterwards according to the method of Jones and Matus (1974) using a discontinuous sucrose density gradient consisting of successive layers of 0.3, 0.8 and 1.0 mM. After centrifugation at 69,000 Â g for 2 h, the fraction at the 0.8-1.0 mM sucrose interface was taken as the membrane enzyme preparation. In some experiments, Gly (0.1-5.0 mM) or alanine (5 mM) was incubated at 37 8C for 30 min with purified synaptic membranes.
CO2 production
Homogenates prepared in Krebs-Ringer bicarbonate buffer, pH 7.4, were added to small flasks (11 cm In some experiments, the incubation medium also contained 1.0 mM coenzyme A. The flasks were gassed with an O 2 /CO 2 (95:5) mixture and sealed with rubber stoppers Parafilm M. Glass center wells containing a folded 60 nm/4 nm piece of Whatman 3 filter paper were hung from the stoppers. After 60 min incubation at 35 8C in a metabolic shaker (90 oscillations min À1 ), 0.2 mL of 50% trichloroacetic acid was supplemented to the medium and 0.1 mL of benzethonium hydroxide was added to the center of the wells with needles introduced through the rubber stopper. The flasks were left to stand for 30 min to complete CO 2 trapping and then opened. The filter paper were removed and added to vials containing scintillation fluid, and radioactivity was counted (Reis de Assis et al., 2004) . Results were calculated as rmol CO 2 h À1 g tissue À1 .
Spectrophotometric analysis of the respiratory chain complexes I-IV activities
The activities of succinate-2,6-dichloroindophenol (DCIP)-oxidoreductase (complex II) and succinate:cytochrome c oxidoreductase (complexes II-III) were determined in homogenates from cerebral cortex according to Fischer et al. (1985) . The activity of NADH:cytochrome c oxidoreductase (complexes I-III) was assayed in cerebral cortex homogenates according to the method described by Schapira et al. (1990) and that of cytochrome c oxidase (complex IV) according to Rustin et al. (1994) . The methods described to measure these activities were slightly modified, as described in details in a previous report (da Silva et al., 2002) . Gly (0.1-5.0 mM) was added to the reaction medium at the beginning of the assays, while no metabolite was added to controls. The activities of the respiratory chain complexes were calculated as nmol min À1 mg protein À1 or mmol min À1 mg protein
À1
.
Spectrophotometric analyses of the activities of citric acid cycle enzymes
The activities of the enzymes of the citric acid cycle (CAC) were determined using enriched mitochondrial fractions from whole brain. Gly was supplemented to the medium and submitted to a pre-incubation at 37 8C for 30 min.
Citrate synthase activity was measured according to Srere (1969) , by determining DTNB reduction at l = 412 nm. The activity of the enzyme aconitase was measured according to Morrison (1954) , following the reduction of NADP + at wavelengths of excitation and emission of 340 and 466 nm, respectively. Isocitrate dehydrogenase activity was accessed by the method of Plaut (1969) , by following NAD + reduction at wavelengths of excitation and emission of 340 and 466 nm, respectively. The activity of a-ketoglutarate dehydrogenase complex was evaluated according to Lai and Cooper (1986) and Tretter and Adam-Vizi (2004) , with slight modifications (Viegas et al., 2009 ). The reduction of NAD + was recorded in a Hitachi F-4500 spectrofluorometer at wavelengths of excitation and emission of 340 and 466 nm, respectively. The activity of succinate dehydrogenase was determined as described by Fischer et al. (1985) . Fumarase activity was measured according to O'Hare and Doonan (1985) , measuring the increase of absorbance at l = 250 nm.
Malate dehydrogenase activity was measured according to Kitto (1969) .
Spectrophotometric analysis of creatine kinase (CK) activity
CK activity was measured in total homogenates as well as in the cytosolic and mitochondrial preparations according to Hughes (1962) with slight modifications (Schuck et al., 2002) . Briefly, the reaction mixture consisted of 50 mM Tris buffer, pH 7.5, containing 7.0 mM phosphocreatine, 7.5 mM MgSO 4 , and 0.5-1.0 mg protein in a final volume of 0.1 mL. Gly (0.1-5.0 mM) was supplemented to the medium and submitted to a pre-incubation at 37 8C for 30 min. The reaction was then started by the addition of 4.0 mM ADP and stopped after 10 min by the addition of 0.02 mL of 50 mM p-hydroxy-mercuribenzoic acid. The creatine formed was estimated according to the colorimetric method of Hughes (1962) . (Tsakiris and Deliconstantinos, 1984) . Released inorganic phosphate (Pi) was measured by the method of Chan et al. (1986) . Enzyme-specific activities were calculated as nmol Pi released À1 min À1 mg protein.
Protein determination
Protein was measured by the methods of Lowry et al. (1951) using bovine serum albumin as standard.
Statistical analysis
Unless otherwise stated, results are presented as mean AE standard deviation. Assays were performed in duplicate or triplicate and the mean or median was used for statistical analysis. Data was analyzed using one-way analysis of variance (ANOVA) followed by the post hoc Duncan multiple range test when F was significant. Linear regression analysis was also employed to detect dose-dependent effects. The Student's t-test for paired samples was used for comparison of two means. Only significant F and t values are shown in the text. Differences between groups were rated significant at p < 0.05. All analyses were carried out in an IBMcompatible PC computer using the Statistical Package for the Social Sciences (SPSS) software.
Results

Glycine inhibits CO 2 production from acetate in rat cerebral cortex
It was first investigated the effect of Gly on CO 2 production from labeled substrates in rat cortical homogenates. We therefore ruled out that the inhibitory effect of Gly could be due to a relative shortage of coenzyme A (CoA) availability due to a competition between Gly and acetate for the CoA leading to reduced acetyl-CoA formation and consequently to low CO 2 production (Fig. 1B) . On the other hand, alanine (up to 5 mM) did not modify CO 2 production from labeled glucose or acetate (data not shown). These results strongly suggest that the citric cycle acid (CAC) activity is compromised by Gly.
Glycine inhibits citrate synthase activity in mitochondrial enriched fractions from whole brain
The next set of experiments was performed in order to evaluate the effect of Gly on CAC enzyme activities in an attempt to elucidate whether the inhibitory effects of this amino acid on CO 2 production from [1-14 C] acetate could be due to an inhibition of one or more steps of the CAC. We found that Gly significantly inhibited citrate synthase activity in mitochondrial enriched fractions from whole brain [F(4,25) = 3.674, p < 0.05] (Fig. 2) . In contrast, this compound did not alter aconitase, isocitrate dehydrogenase, a-ketoglutarate dehydrogenase, . *p < 0.05, **p < 0.01 and ***p < 0.001, compared to controls (ANOVA followed by Duncan multiple range test). succinate dehydrogenase, fumarase or malate dehydrogenase activities (Table 1) . These data are in agreement with the fact that CO 2 formation from citrate was not altered by Gly. Therefore, inhibition of citrate synthase activity is probably responsible for the inhibitory action of Gly on the CAC (lower CO 2 production).
Glycine inhibits complexes I-III, II and II-III activity of the respiratory chain in rat cerebral cortex
The next step of experiments was designed to investigate the effect of Gly on the various respiratory chain complex enzyme activities in an attempt to elucidate whether the electron transfer flow could be altered by Gly. We found that Gly significantly inhibited complexes I-III [F(4,15 (Fig. 3) , with no significant alteration of complex IV activity.
Glycine inhibits creatine kinase activity from rat cerebral cortex
We then examined the effect Gly on total creatine kinase (tCK) activity in homogenates from rat cerebral cortex. Gly significantly inhibited tCK activity [F(4,25) = 16.875, p < 0.05] in a dosedependent manner (b = À0.780, p < 0.01) (Fig. 4A) . Fig. 4C shows that the activity on mitochondrial CK (mCK) was significantly inhibited by Gly [F(4,25) = 2.982, p < 0.05; b = À0.422, p < 0.05], with no alteration of the cytosolic CK isoform (cCK) (Fig. 4B) in rat cerebral cortex. In contrast, tCK activity was not altered by alanine (up to 5 mM) (data not shown). 
Discussion
Patients affected by nonketotic hyperglycinemia (NKH) commonly present severe neurological dysfunction with acute encephalopathy and intractable convulsions. The biochemical , respectively. No significant differences were detected (one-way ANOVA). hallmark of this disorder is the accumulation of glycine (Gly), mainly in the brain and CSF, which may achieve 5 mM, but also in the blood and urine especially during episodes of acute decompensation. Although severe cerebral damage characterized by progressive cortical brain atrophy with leukodystrophy of the white matter is usually seen in the affected patients, the underlying mechanisms involved in the neuropathology of this disease are poorly known. In this context, it has been postulated that excitotoxicity may be involved in this disorder since Gly stimulates the NMDA glutamate receptors (Patel et al., 1990; McNamara and Dingledine, 1990; Hara et al., 1993; Kure et al., 1997; Kono et al., 2007; Katsuki et al., 2007) , acting as a co-agonist of these receptors. However, more studies are necessary to unravel the pathomechanisms of brain injury in NKH. Hyperglycinemia is also characteristic of methylmalonic acidemia and propionic acidemia (previously known as ketotic hyperglycinemia), two inherited metabolic disorders characterized by severe neurological dysfunction and brain cortical atrophy. Recently, mitochondrial dysfunction has been reported in patients with methylmalonic acidemia (Schwab et al., 2006) .
In the present study, we investigated the in vitro effects of Gly on various parameters of energy metabolism in cerebral cortex of young rats in the hope to verify whether Gly could compromise brain energy homeostasis. We initially verified that Gly did not affect 14 CO 2 formation from glucose in brain cortex, suggesting that the glycolytic pathway was not affected by Gly. In contrast, acetate oxidation was markedly reduced by the presence of Gly in the incubation medium. Assays with coenzyme A supplementation showed that shortage of this coenzyme could not be responsible for the Gly-induced reduction of 14 CO 2 production. The data indicate that the citric acid cycle (CAC) activity was disturbed by Gly. This could be due to an inhibition of one or more steps of the CAC or alternatively secondary to a blockage of the transport of electrons trough the respiratory chain. We also observed that 14 CO 2 production from citrate was not altered by the presence of Gly, indicating that CAC activity from citrate downwards was not affected by this amino acid and that the probable site of blockage was between acetate and citrate synthesis. The next step of the investigation was therefore to evaluate whether Gly could alter the enzyme activities of the CAC. We verified that citrate synthase was significantly inhibited by Gly, whereas aconitase, isocitrate dehydrogenase, a-ketoglutarate dehydrogenase, succinate dehydrogense, fumarase and malate dehydrogenase activities were not changed by this compound. These results probably explain the reduction of CO 2 generation and indicate that Gly blocks the CAC by inhibiting the first step of this cycle.
We also tested the effects of Gly on the respiratory chain function by measuring the activities of complexes I-IV. We found that Gly significantly inhibited the activities of the respiratory chain complexes I-III, II and II-III, without affecting complex IV activity, implying that it reduces the electron transport chain flow, involved in almost all energy (ATP) produced in the cell. Taken together these data, it can be presumed that energy production is compromised by Gly in cerebral cortex of young rats.
We also demonstrated here that mCK activity, which is essential for intracellular energy buffering and transference, was inhibited by Gly. These observations are important since this enzyme activity, mainly responsible for ATP buffering and transfer within the cell, is crucial for normal brain cell functioning and has been recognized as an important metabolic regulator during health and disease (Wyss et al., 1992; Hamman et al., 1995 ; Gross et al., . *p < 0.05, **p < 0.01 and ***p < 0.001, compared to control (ANOVA followed by Duncan multiple range test). 1996; Holtzman et al., 1997; Wallimann et al., 1998) . It should be stressed that mCK activity decreases after brain exposure to agents promoting generation of free radicals probably by oxidation of essential cysteine residues of the enzyme (Burmistrov et al., 1992; Wolosker et al., 1999; Arstall et al., 1998; Konorev et al., 1998; Stachowiak et al., 1998; Wallimann et al., 1998) and that we have recently demonstrated that Gly elicits lipid and protein oxidation and decreases GSH concentrations in rat brain (Leipnitz et al., 2008) .
Finally, Na + ,K + -ATPase activity was also significantly inhibited when Gly was exposed to purified plasma synaptic membranes from rat brain. Na + ,K + -ATPase is a crucial enzyme responsible for the generation of the membrane potential through the active transport of sodium and potassium ions in the CNS, necessary to maintain neuronal excitability and cellular volume control. It is present at high concentrations in the brain cellular membrane, consuming about 40-50% of the ATP generated in this tissue, and is highly responsive to changes in membrane fluidity (Wheeler et al., 1975; Erecinska and Silver, 1994; Erecinska et al., 2004) . Maintenance of Na + ,K + -ATPase activity is critical for normal brain function, and reduction of its activity is related to selective neuronal damage in rat and human brain (Lees et al., 1990; Lees, 1993; Cousin et al., 1995; Lees and Leong, 1995) . As regards to the mechanism of Gly-induced decrease of Na
increasing evidence is emerging demonstrating that Na + ,K + -ATPase is highly vulnerable to free radical attack (Lees, 1993; Kurella et al., 1997; Yousef et al., 2002) . Therefore, we cannot rule out that Gly elicited free radicals, reducing Na there is increasing evidence suggesting that alterations in Na + ,K + -ATPase activity may be a link between common neurotoxic mechanisms in neurons (Sweadner, 1979; Lees, 1991 Lees, , 1993 Satoh and Nakazato, 1992) . Furthermore, inhibition of Na + ,K + -ATPase has also been associated with excitotoxicity and epilepsy (Grisar, 1984; Ben-Ari, 1985; Choi and Rothman, 1990; Cousin et al., 1995; Lees and Leong, 1995) .
On the other hand, since alanine was not able to affect CO 2 production from labeled glucose or acetate, as well as creatine kinase and Na + ,K + -ATPase activities, it may be concluded that the Gly effects on brain bioenergetics were specific for this amino acid. It is difficult to determine the pathophysiological relevance of our in vitro data. However, it should be noted that the effects observed in our present investigation occurred with Gly tissue levels similar or even lower than those found in NKH and ketotic hyperglycinemia (Hamosh and Johnston, 2001) . It is also feasible that even higher brain Gly concentrations may take place in stress situations, such as occurs in various inborn disorders during episodes of metabolic decompensation characterized by intense catabolism and proteolysis in which the levels of the accumulating metabolites within neural cells predominate over those found in plasma and CSF (Hoffmann et al., 1993) . Furthermore, although we cannot assume that the degree of inhibition found in our experiments (up to 35%) is deleterious to the neural cells, this may be the case since they affect crucial steps involved in ATP formation (citric acid cycle activity and oxidative phosphorylation), transfer (creatine kinase activity) and utilization (Na + ,K + -ATPase activity) that may lead to apoptosis (Lees and Leong, 1995; Gibson et al., 2010) .
On the other hand, alterations in the expression and function of Gly transporters in different neural cell types at both synaptic and nonsynaptic regions were recently shown to be involved in various physiological and pathological processes, including ischemia and neurodegeneration (Papp et al., 2007; Raiteri et al., 2007) . Additionally, Gly transporters are also involved in the interactions between the various neurotransmitter systems (Kalló et al., 2007; Sershen et al., 2008; Brouns et al., 2010) , so that it cannot be ruled out that high brain Gly concentrations may affect these mechanisms and play an important role in the pathophysiology of NKH.
In conclusion, this is the first report showing that Gly provokes bioenergetics dysfunction in the brain. In case the present in vitro data are confirmed in vivo in animal experiments, it is tempting to speculate that impairment of energy production, transfer and utilization may contribute synergistically with other susceptibility factors, such as oxidative stress (Leipnitz et al., 2008) and excitotoxicity (Patel et al., 1990; Katsuki et al., 2007; Kono et al., 2007) , to the neurological damage found in patients affected by NKH and ketotic hyperglycinemia. In this scenario, the prompt and aggressive treatment of infections and management of fever during acute metabolic decompensation reducing the risk of increased catabolism with elevation of brain Gly concentrations seems justified and may prevent irreversible brain injury with consequent cognitive impairment and seizures in these patients.
